A deadly hantavirus outbreak aboard the Dutch-operated cruise ship MV Hondius unfolded for nearly a month before health officials identified what was happening, turning what began as isolated illnesses into an international health scare involving multiple countries, emergency evacuations and at least three deaths.
The outbreak began quietly in early April after the expedition-style cruise departed from Argentina on a voyage that included Antarctica and remote islands across the South Atlantic. According to the World Health Organization, the first known passenger became sick on April 6. The infected passenger, a 70-year-old Dutch man, reportedly developed fever and respiratory symptoms while the ship continued its journey through isolated waters far from major medical facilities.
At the time, no one suspected hantavirus. Early symptoms resembled the flu, including fever, fatigue, muscle aches and gastrointestinal problems. Because the ship was traveling through remote regions with limited access to hospitals and testing, the illness did not immediately trigger alarms.
The Dutch passenger died aboard the ship on April 11, but officials still had not identified the virus responsible. The ship continued sailing, stopping near South Georgia, St. Helena and Ascension Island as more passengers and crew slowly began showing symptoms.
Two weeks after the first death, the man’s wife became seriously ill and was evacuated to South Africa for treatment. She later died in a hospital there on April 26. Around the same time, additional passengers started developing severe respiratory illness, including pneumonia-like symptoms and acute respiratory distress.
By late April, authorities realized something more dangerous might be unfolding aboard the vessel. A British passenger became critically ill and was airlifted to Johannesburg, South Africa, for emergency care. Another passenger, a German woman, later died on board the ship on May 2.
Only after several deaths and multiple severe illnesses did investigators begin connecting the cases to hantavirus, a rare but potentially deadly disease typically spread through contact with rodent urine, saliva or droppings. The World Health Organization officially announced the outbreak on May 2.
Health officials believe the outbreak may have originated before passengers even boarded the ship. Investigators suspect at least one infected traveler contracted the Andes strain of hantavirus in South America before embarking on the cruise. That strain is especially concerning because it is the only known hantavirus capable of limited human-to-human transmission.
WHO officials later acknowledged that some human-to-human spread aboard the ship could not be ruled out, especially among passengers who had close contact with infected individuals.
The outbreak exposed the unique dangers of infectious diseases on cruise ships, particularly expedition cruises operating far from major ports. The MV Hondius carried nearly 150 passengers and crew from 23 countries while traveling through isolated parts of the Atlantic Ocean, complicating testing, evacuation and containment efforts.
As the situation worsened, passengers were isolated in cabins while crew members implemented emergency sanitation protocols. Cape Verde initially refused to allow the ship to dock as officials scrambled to assess the risk. The vessel eventually rerouted toward the Canary Islands while international health agencies coordinated evacuations and contact tracing efforts across several countries.
By early May, the WHO confirmed at least two laboratory-confirmed cases and five suspected infections, though officials warned the number could rise as testing continued. One former passenger in Switzerland later tested positive after leaving the ship, prompting further international monitoring.
The outbreak has become one of the most unusual maritime disease incidents since the COVID-19 pandemic, partly because hantavirus outbreaks on cruise ships are extraordinarily rare. Experts say the incident demonstrates how difficult it can be to recognize emerging diseases in confined environments where symptoms initially resemble common illnesses.
